NCT02991495View on ClinicalTrials.gov

Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)

PHASE4CompletedINTERVENTIONAL
Enrollment

1,630

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

February 21, 2018

Study Completion Date

December 31, 2021

Conditions
Yellow Fever
Interventions
BIOLOGICAL

Stamaril, Sanofi Pasteur

"1. Full dose~2. Fractional dose: one fifth (1/5)"

BIOLOGICAL

Yellow fever vaccine, Bio-Manguinhos

"1. Full dose~2. Fractional dose: one fifth (1/5)"

BIOLOGICAL

Yellow fever vaccine, Institut Pasteur

"1. Full dose~2. Fractional dose: one fifth (1/5)"

BIOLOGICAL

Yellow fever vaccine, Chumakov Institute

"1. Full dose~2. Fractional dose: one fifth (1/5)"

BIOLOGICAL

Yellow fever vaccine, Chumakov Institute

"1. Full dose~2. Fractional dose: one fifth (1/5)"

BIOLOGICAL

Yellow fever vaccine, Chumakov Institute

"1. Full dose~2. Fractional dose: one fifth (1/5)"

Trial Locations (2)

Unknown

KEMRI, Kilifi

Epicentre, Mbarara

Sponsors

Lead Sponsor

Epicentre
All Listed Sponsors
collaborator

Kenya Medical Research Institute

OTHER

lead

Epicentre

OTHER